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Summary
The neural crest is one of the embryonic structures with the broadest developmental potential in
vertebrates. Morphologically, neural crest cells emerge during neurulation in the dorsal folds of the
neural tube before undergoing an epithelial-to-mesenchymal transition (EMT), delaminating from
the neural tube, and migrating to multiple sites in the growing embryo. Neural crest cells generate
cell types as diverse as peripheral neurons and glia, melanocytes, and so-called mesectodermal
derivatives that include craniofacial bone and cartilage and smooth muscle cells in cardiovascular
structures. In mice, the fate of neural crest cells has been determined mainly by means of transgen-
esis and genome editing technologies. The most frequently used method relies on the Cre-loxP
system, in which expression of Cre-recombinase in neural crest cells or their derivatives genetically
enables the expression of a Cre-reporter allele, thus permanently marking neural crest-derived
cells. Here, we provide an overview of the Cre-driver lines used in the field and discuss to what
extent these lines allow precise neural crest stage and lineage-specific fate mapping.
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1 | A BRIEF SYNOPSIS OF METHODS USED
FOR NEURAL CREST CELL FATE MAPPING
The astonishing variety of neural crest derivatives has long been recog-
nized, mainly through the pioneering work by Le Douarin and co-
workers who used interspecies transplantation in avian embryos to
determine normal fates as well as the developmental potential of
neural crest cell populations from different axial levels of the
embryo (Bronner & Sim~oes-Costa, 2016; Le Douarin & Dupin,
2003). Together with assays involving dye labeling and retroviral
infection of neural crest cells, this approach led to the establishment
of comprehensive fate maps and revealed that certain neural crest
derivatives (such as peripheral glia, sensory neurons, and melano-
cytes) are produced from all axial levels, whereas other neural crest
cell lineages (such as cartilage, bone, smooth muscle, connective tis-
sue, endocrine cells as well as, for instance, neurons and glia from
the enteric and parasympathetic nervous system) originate from dis-
crete levels along the neuraxis.
Given the limited accessibility of mammalian embryos, lineage-
tracing experiments as performed in avian embryos have not been
widely used for fate mapping of mammalian neural crest cells. Rather,
various genetic tools have been established that allow noninvasive and
long-term tracing of neural crest cells in mice in vivo (Zurkirchen &
Sommer, 2017). By far the most frequently used approach in the field
is Cre-loxP-based conditional genetic recombination that, when com-
bined with a Cre-reporter line, results in inheritable and irreversible
expression of a marker gene in Cre-recombinase-expressing cells and in
all of their progeny (Woodworth, Girskis, & Walsh, 2017). Furthermore,
inducible forms of Cre-recombinase have been applied to perform
stage-dependent fate mapping of neural crest cells and their derivatives
or fate mapping at low recombination density for in vivo single cell
tracing (Baggiolini et al., 2015; Kaucka et al., 2016). Apart from confirm-
ing in mice many of the findings obtained by fate mapping of avian
neural crest cells, genetic lineage tracing of murine neural crest cells
led, for instance, to the identification of minor neural crest-derived cell
populations present in tissues of nonneural crest origin, to the
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establishment of novel lineage trees (revealing, in particular, the broad
developmental potential of peripheral glial cells), and to the demonstra-
tion of in vivo multipotency of single premigratory and migratory neural
crest cells. While these studies have recently been covered elsewhere
(Petersen & Adameyko, 2017; Zurkirchen & Sommer, 2017), in the
present review we aim to focus on the tool set used in the field, sum-
marizing the findings made with and discussing specific properties of
various Cre lines that have been utilized to trace neural crest cells.
2 | TRACING OF PREMIGRATORY AND
MIGRATORY NEURAL CREST CELLS USING
NONINDUCIBLE CRE-DRIVER LINES
A well-established Cre-driver line for neural crest lineage tracing is
Wnt1-Cre (Danielian, Muccino, Rowitch, Michael, & McMahon, 1998)
(Table 1). This transgenic mouse line expresses Cre initially in the mid-
brain and, after closure of the neural tube, in the midlines of the mid-
brain and the caudal diencephalon, in the midbrain–hindbrain junction,
and in the dorsal spinal cord, where it recombines premigratory neural
crest cells. By crossing Wnt1-Cre mice with the ROSA26 (R26R)
Cre-reporter line (that drives b-galactosidase expression upon Cre-
mediated recombination) (Soriano, 1999), it was shown that Wnt1-Cre
is a highly efficient Cre-driver line, resulting in recombination of approx-
imately 96% of all migratory neural crest cells (Hari et al., 2012).
Because Wnt1 is not expressed in migratory neural crest cells and Wnt
activity rapidly decreases in neural crest cells after their delamination
from the neural tube (Kleber et al., 2005; Rabadan et al., 2016; Zervas,
Millet, Ahn, & Joyner, 2004), it can be assumed that most neural crest
cells are very efficiently targeted by Wnt1-Cre before or at the time of
their delamination. Intriguingly, however, despite the early activity of
Wnt1-Cre in the dorsal neural tube, recombination apparently occurs
too late to allow investigation of mechanisms regulating epithelial-to-
mesenchymal transition (EMT) or delamination of neural crest cells.
Indeed, Wnt1-Cre-mediated ablation of signaling pathways shown in
other animal models to be crucial for neural crest EMT, such as canoni-
cal Wnt signaling and signaling by TGFb superfamily factors, did not
affect early stages of neural crest development (Brault et al., 2001;
B€uchmann-Møller et al., 2009; Hari et al., 2002; Jia et al., 2007). In
contrast, the differentiation potential of neural crest cells along all axial
levels could readily be monitored using Wnt1-Cre, both during develop-
ment and at postnatal stages (Chai et al., 2000; Jiang, Rowitch, Soriano,
McMahon, & Sucov, 2000; Zurkirchen & Sommer, 2017). A potential
caveat of this line is, however, that, at least in the midbrain, Wnt1 is
ectopically expressed from theWnt1-Cre transgene, which could lead to
ectopic activation of canonical Wnt signaling (Lewis, Vasudevan, O’neill,
Soriano, & Bush, 2013). Although it is not known whether such ectopic
Wnt1 expression also affects the neural crest, the use of a new driver
line termed Wnt1-Cre2 should be considered (Lewis et al., 2013). In
TABLE 1 List of publicly available neural crest drivers
Premigratory neural crest drivers
Short name Official Name Original study
P3Pro-Cre Tg(Pax3-cre)1Joe Li et al. (2000)
Wnt1-Cre H2afvTg(Wnt1-cre)11Rth Danielian et al. (1998)
Wnt1-Cre2 E2f1Tg(Wnt1-cre)2Sor Lewis et al. (2013)
Wnt1-CreER Tg(Wnt1-cre/ERT)1Alj Zervas et al. (2004)
Wnt1-Flpe Tg(Wnt1-FLP1)1Dym Dymecki et al. (1998)
Wnt1-FlpeERT2 Tg(Wnt1-flpe/ERT2)9455Dym Hunter et al. (2005)
Migratory neural crest drivers
Short name Official name Original study
AP2a-IRESCre Tfap2atm1(cre)Moon Macatee et al. (2003)
Ht-PA-Cre Tg(PLAT-cre)116Sdu Pietri et al. (2003)
Mef2c-F10N-Cre Tg(Mef2c-cre)5Patr Aoto et al. (2015)
P0-Cre Tg(Mpz-cre)94Imeg Yamauchi et al. (1999)
Plp-CreERT Tg(Plp1-cre/ERT)3Pop/J Doerflinger et al. (2003)
Plp-CreERT2 Tg(Plp1-cre/ERT2)1Ueli Leone et al. (2003)
Sox10-Cre Tg(Sox10-cre)1Wdr Matsuoka et al. (2005)
Sox10ERT2CreERT2 (SECE) Tg(Sox10-ERT2/cre/ERT2)17Sor He and Soriano (2015)
Sox10-iCreERT2 Tg(Sox10-icre/ERT2)1Ldim Simon et al. (2012)
Sox10-iCreERT2 Tg(Sox10-icre/ERT2)26Vpa Laranjeira et al. (2011)
Sox10-iCreERT2 Tg(Sox10-icre/ERT2)388Wdr McKenzie et al. (2014)
TEC1 Tg(Tyr-cre)1Gfk Tonks et al. (2003)
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fact, in studies addressing the role of fibronectin in cardiac neural crest
development, considerable phenotypic variances have been reported
upon Wnt1-Cre vs. Wnt1-Cre2-mediated recombination, although this
could have been due to differences between the two transgenic lines
other than aberrant Wnt1 expression (Wang & Astrof, 2016).
Apart from the Cre/loxP system, another site-specific recombina-
tion system has also been established to trace the fate of neural crest
cells. To this end, two transgenic mouse lines (termed Wnt1-Flpe mice)
were independently generated that express Flp recombinase from the
Wnt1 promoter (Dymecki & Tomasiewicz, 1998; Hatzistergos et al.,
2015). Although the recombination efficiency and the extent of neural
crest lineages traceable by these lines have not been described in
detail, these lines were instrumental to perform intersectional lineage
tracing of cells that concurrently express two distinct promoters. When
combined with either the RC::FrePe (Engleka et al., 2012) or RC::Fela
(Jensen et al., 2008) dual reporter alleles (which report dual Flp and Cre
recombination), a fraction of cKit-CreERT2-traced cardiac progenitors
was shown to derive from the cardiac neural crest (traced by Wnt1-
Flpe) (Hatzistergos et al., 2015). Likewise, intersectional fate-mapping
with the RC::FrePe allele was used to demonstrate that Isl1 is not an
exclusive marker for second heart field cardiac progenitors, as previ-
ously suggested, but also marks a subpopulation of cardiac neural crest
cells (Engleka et al., 2012).
Another mouse line expressing Cre in the dorsal neural tube and
premigratory neural crest is P3Pro-Cre, in which Cre expression is
driven from a Pax3 promoter fragment (Li, Chen, & Epstein, 2000).
Although Pax3 is expressed in the neural plate border before bona fide
neural crest specification (Bronner & Sim~oes-Costa, 2016), Cre-
mediated conditional inactivation of pathways controlling EMT/delami-
nation did not affect neural crest cell production and early migration in
P3Pro-Cre embryos (Buchmann-Moller and Sommer, unpublished).
Thus, we are not aware of a Cre-driver line suitable for the study of
early events in neural crest development, including neural crest specifi-
cation, EMT, and delamination. Fate mapping experiments with P3Pro-
Cre have demonstrated efficient labeling of postmigratory neural crest
derivatives, such as the enteric nervous system, the mesenchyme in
pharyngeal arches, and cardiovascular structures. In contrast to the
Wnt1-Cre line, however, P3Pro-Cre-mediated recombination appears to
be less specific for neural crest lineage tracing as it also marks noncrest
neuroepithelial cells and several mesodermal tissues, including cartilagi-
nous portions of the ribs and a large part of the skeletal musculature
(Jarad & Miner, 2009; Li et al., 2000; Liu et al., 2006; Lang et al. 2000).
Several Cre-driver lines have been generated that, unlike the
Wnt1-Cre or P3Pro-Cre lines, express Cre-recombinase in neural crest
cells not before they undergo an EMT in the dorsal neural tube, but
only as the cells begin to migrate. For instance, transgenic Ht-PA-Cre
mice express Cre under the control of a human tissue plasminogen acti-
vator (Ht-PA) promoter fragment specifically in migratory neural crest
cells (Pietri, Eder, Blanche, Thiery, & Dufour, 2003). A detailed compari-
son with Wnt1-Cre/R26R mice revealed very efficient labeling of neural
crest derivatives by Ht-PA-Cre, including neuronal, glial, melanocytic,
and mesenchymal cell populations during development and in adult
structures (Pietri et al., 2003; Wong et al., 2006). Ht-PA-Cre/R26R mice
were also reported to label a fraction of nonneural epithelial cells lateral
to cranial neural folds that were suggested to contribute to mesecto-
dermal structures in the head (Breau, Pietri, Stemmler, Thiery, &
Weston, 2008).
Additional Cre-driver lines mostly used to study cranial and cardiac
neural crest development are the transgenic lineMef2c-F10N-Cre (Aoto
et al., 2015) and the AP2a-IRESCre line generated by knock-in of an
IRESCre cassette into the 30 untranslated region of the AP2a transcrip-
tion factor locus (Macatee et al., 2003). A detailed analysis of Mef2c-
F10N-Cre/R26R embryos at different stages confirmed the neural crest
origin of various neural and nonneural structures and emphasized the
neural crest origin of olfactory ensheathing glial cells, cells in the
meninges surrounding the forebrain, and cells of the choroid plexus.
Apart from marking migratory neural crest cells only after delamination
from the neural tube, Mef2c-F10N-Cre/R26R presented a neural crest
fate map highly similar to the one obtained with the Wnt1-Cre line,
with the exception of some differences apparent in the calvarial bones
(Aoto et al., 2015).
Tyrosinase (Tyr) is a key enzyme of the melanin biosynthetic path-
way and, accordingly, a transgenic mouse line, in which Tyr enhancer
and promoter elements drive Cre expression, was found to mark the
melanocytic lineage, but not other neural crest derivatives (Delmas,
Martinozzi, Bourgeois, Holzenberger, & Larue, 2003). In contrast, an
independently produced Tyr-Cre line termed TEC1 also marks neural
crest lineages other than melanoblasts, such as craniofacial structures,
dorsal root ganglia (DRG), and sympathetic cephalic ganglia, albeit at a
seemingly low recombination efficiency and at a relatively late stage in
neural crest development (embryonic day (E) 10.5 onwards) (Tonks
et al., 2003). Whether this reflects activity of tyrosinase transcriptional
elements in a subset of undifferentiated migratory neural crest cells or
aberrant transgene expression remains to be determined.
Although P0 was originally identified as a marker of the peripheral
glial lineage, the expression of P0-Cre in transgenic mice was not line-
age restricted, but detected already in migratory neural crest cells
(Yamauchi et al., 1999). Consequently, P0-Cre/R26R mice displayed
b-galactosidase expression in multiple neural and nonneural tissues
originating from the neural crest. However, at least in some structures
such as the DRG, the recombination efficiency appeared to be consid-
erably lower than the one achieved by Wnt1-Cre-mediated recombina-
tion. Furthermore, cranial neural crest cell populations are differentially
marked in Wnt1-Cre vs. P0-Cre mice: Wnt1-Cre preferentially recom-
bines midbrain as opposed to hindbrain neural crest cells, while hind-
brain neural crest cells are efficiently targeted by P0-Cre (Chen et al.,
2017). Intriguingly, fate-mapping experiments by means of the P0-Cre
line also allowed the identification of neural crest-derived cells in struc-
tures previously not known to harbor such cells. Specifically, Nagoshi
and colleagues demonstrated that neural crest cells give rise to vascular
endothelial and smooth muscle cells present in the adult bone marrow,
which was later confirmed in Wnt1-Cre mice (Nagoshi et al., 2008;
Wislet-Gendebien et al., 2012). Likewise, between 5 and 15% of all
hormone-producing cells in the anterior lobe of the pituitary turned out
to originate from the neural crest based on P0-Cre- lineage tracing
(Ueharu et al., 2017).
DEBBACHE ET AL. | 3 of 8
Yet another transgenic mouse line expressing Cre in neural crest
cells only once they have engaged in migration is Sox10-Cre (Hari et al.,
2012; Matsuoka et al., 2005). Fate mapping in Sox10-Cre/R26R
embryos, combined with immunostaining for Cre protein, demon-
strated targeting of approximately 78% of all Sox10-positive neural
crest cells after their emigration from the neural tube (Hari et al., 2012).
Thanks to this high recombination efficiency it was possible to address
stage-specific functions of canonical Wnt signaling upon constitutive
activation in premigratory neural crest (using Wnt1-Cre) vs. migratory
neural crest cells (using Sox10-Cre). Furthermore, the Sox10-Cre line
was used together with the Wnt1-Cre line to show an unexpected con-
tribution of neural crest cells in the murine neck region to muscle con-
nective tissue, cartilage and bone, including endochondral bones that
were till then believed to exclusively originate from the mesoderm
(Matsuoka et al., 2005). However, unlike Wnt1-Cre, Sox10-Cre activity
leads to recombination of some adult structures that are not of neural
crest origin, such as subpopulations of epithelial cells present in hair
follicles (Figure 1).
3 | NEURAL CREST LINEAGE TRACING
USING INDUCIBLE CRE-DRIVER LINES
The above-described Cre lines allow in vivo fate mapping or functional
analysis of a gene of interest only at the first time the Cre-driving pro-
moter is active. To temporally control Cre activity, inducible forms of
Cre have been developed, for instance by fusion with a mutant ligand-
binding domain of the human estrogen receptor (CreER) that bind to
the synthetic estrogen receptor ligand 4-hydroxytamoxifen (4-OHT) or
tamoxifen (TM), but not to endogenous estradiol (Feil et al., 1996). Sub-
sequently, a refined version with a higher TM sensitivity was con-
structed (termed CreERT2) (Feil, Wagner, Metzger, & Chambon, 1997).
Although some mouse lines expressing inducible forms of Cre display
leakiness, CreER- and CreERT2-expressing lines have become very valu-
able tools to determine stage-specific roles of genes of interest, to
carry out lineage tracing experiments at different stages of neural crest
development, or to perform clonal analyzes of neural crest cells in vivo
by choosing conditions enabling low recombination frequencies (Zur-
kirchen & Sommer, 2017).
Because Wnt1 is only expressed in premigratory neural crest, but
not once neural crest cells have emigrated from the neural tube, Wnt1-
CreER and Wnt1-FlpeERT2 mice (generated to study lineage relation-
ships of cells at the mid/hindbrain boundary (Hunter, Awatramani, Far-
ley, & Dymecki, 2005; Zervas et al., 2004)) (Table 1) are not suitable for
neural crest lineage tracing at different time points. However, the
Wnt1-CreER line has been successfully used in conjunction with the
multicolor Cre-reporter allele R26R-Confetti (Snippert et al., 2010) to
show that premigratory Wnt1-expressing neural crest cells are multipo-
tent in vivo (Baggiolini et al., 2015). In this study, low dose TM treat-
ment of pregnant mice led to low density recombination of the
multicolor Cre-reporter in neural crest cells homozygous for R26R-Con-
fetti, resulting in clones of cells expressing either nuclear green, cyto-
plasmic yellow, cytoplasmic red, membrane-bound blue, or rare
combinations thereof. Intriguingly, around 20% of all the clones derived
FIGURE 1 Adult skin structures traced by Wnt1-Cre and Sox10-Cre-driven recombination. Immunolabeling of adult skin from mice, in
which recombination of the Cre-reporter allele R26R-tdTomato was driven during neural crest development by Wnt1-Cre (Danielian et al.,
1998) and Sox10-Cre (Matsuoka et al., 2005), respectively. Genetically recombined cells are labeled with tdTomato (red) in combination with
selected lineage markers (green): DCT (melanocytes in hair follicles (HF)); NF (axons of nerves in nerve bundles (NB)). Aberrant tracing of
some keratinocytes (white arrows) can be observed with Sox10-Cre. Hoechst nuclei counterstaining, scale bars 50 mm. The schematics sum-
marize the neural crest lineage-specific and unspecific recombination events observed with these Cre-driver lines. Star-like cells: melano-
cytes; cells in hair bulges: glial cells and melanocyte stem cells; cells in NBs: Schwann cells
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from single Wnt1-CreER-traced neural crest cells not only contributed
to multiple neural crest cell lineages, but also contained daughter cells
in the dorsal neural tube. These data are consistent with the idea that
at least some premigratory neural crest cells self-renew in vivo.
The assumption that multipotent neural crest cells can self-renew
during a given time window was further supported by clonal analysis of
migratory neural crest cells, traced shortly after emigration by means of
a Sox10-iCreERT2 driver line (Baggiolini et al., 2015; Simon, Lickert,
G€otz, & Dimou, 2012). By using R26R-Confetti as Cre-reporter in
Sox10-iCreERT2 mice treated with low TM doses, the vast majority of
migratory neural crest cells were shown to maintain multipotency, and
the Sox10-iCreERT2-expressing cells did not display any higher degree
of fate restriction as compared to their premigratory counterparts (Bag-
giolini et al., 2015). The only structure labeled by Wnt1-CreER– but not
Sox10-iCreERT2–lineage tracing was the dorsal neural tube, confirming
that Sox10-iCreERT2 is not expressed in the premigratory neural crest,
but only once the cells start to migrate. R26R-Confetti-based clonal
analysis of neural crest cells has also been performed with another,
independently produced Sox10-iCreERT2 line (Kaucka et al., 2016; Lar-
anjeira et al., 2011). In this study, composition and behavior of ectome-
senchymal cranial neural crest-derived clones were monitored during
early craniofacial development, revealing that cranial neural crest cell-
derived clones frequently comprise odontogenic, chondrogenic, osteo-
genic, and adipogenic cells.
Sox10 is not only expressed in migratory neural crest cells, but its
expression is maintained throughout development and postnatally in
the glial and melanocyte lineage, including in adult tissue (Bremer et al.,
2011; Kuhlbrodt, Herbarth, Sock, Hermans-Borgmeyer, & Wegner,
1998; Shakhova et al., 2012). Moreover, it marks cells with neural crest
stem cell (NCSC) features that have been isolated from various adult
neural crest-derived structures (Shakhova & Sommer, 2010). Impor-
tantly, reporter expression in Sox10-iCreERT2 lines nicely matches the
known Sox10 expression pattern during development and in the adult
(Laranjeira et al., 2011; Simon et al., 2012). Thus, these Sox10-CreERT2
lines (Laranjeira et al., 2011; Simon et al., 2012) are ideally suited to
monitor whether neural crest-derived cells give rise to distinct cell pop-
ulations at different time points or to assess stage-specific roles of
genes of interest. In fact, the Sox10-iCreERT2 line by Laranjeira and col-
leagues has been used to show that glia in the adult enteric nervous
system are able to produce neurons upon injury (Laranjeira et al., 2011)
or that cells in peripheral nerves can give rise to parasympathetic neu-
rons, dental mesenchymal cells, or neuroendocrine chromaffin cells in
the adrenal medulla (Dyachuk et al., 2014; Furlan et al., 2017; Kaukua
et al., 2014). Such studies might also be possible with yet another inde-
pendently generated Sox10-iCreERT2 line (McKenzie et al., 2014) or
with a Sox10ERT2CreERT2 line termed SECE (He & Soriano, 2015). Of
note, while high dose TM treatment in SECE/R26R embryos resulted in
labeling of multiple neural and nonneural neural crest derivatives, low
dose application of TM was found to affect the reporter gene expres-
sion pattern, allowing the tracing specifically of cranial as opposed to
trunk neural crest cells (He & Soriano, 2015).
Another genetic tool suitable for neural crest cell fate mapping at
different developmental stages is a Plp-CreERT2 mouse line generated
by Leone and colleagues (Leone et al., 2003). Plp is a glia-specific
FIGURE 2 Sox10-iCreERT2 and Plp-CreERT2-mediated tracing of adult neural crest-derived cells in the skin. Immunolabeling of adult skin of
tamoxifen-free animals carrying inducible Sox10-iCreERT2 (Simon et al., 2012) and Plp-CreERT2 (Leone et al., 2003), respectively, reveals leaki-
ness of these driver lines in combination with the Cre-reporter allele R26R-tdTomato (red) in melanocyte stem cells and glial cells present in
or around the hair bulge, melanocytes (DCT (green); star-like cells in the schematics), and Schwann cells in nerve bundles (NB). NF marks
axons of nerves. Hoechst nuclei counterstaining, scale bars 50 mm. Note that tamoxifen treatment of adult animals results in significantly
enhanced CreERT2 activity in peripheral glia and melanocytes in both Sox10-iCreERT2 and Plp-CreERT2 lines (Parfejevs et al., 2018)
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marker, and the Plp gene regulatory elements used to drive CreERT2
expression in these mice were reported to direct specific transgene
expression in oligodendrocytes and Schwann cells. Accordingly, TM-
induced recombination during embryonic development and in adult
mice led to very efficient labeling of peripheral glia in PLP-CreERT2/
R26R double transgenic animals (approximately 80% upon TM injection
of adult mice) (Leone et al., 2003). Moreover, using this line, an unex-
pectedly broad developmental potential of peripheral glial cells was
revealed, with Plp-CreERT2-traced cells along peripheral nerves giving
rise to cell types as diverse as melanocytes, parasympathetic neurons,
mesenchymal cells in teeth, and chromaffin cells of the adrenal medulla
(Adameyko et al., 2009; Dyachuk et al., 2014; Furlan et al., 2017; Kau-
kua et al., 2014; Petersen & Adameyko, 2017). The glial origin of at
least some melanocytes was also suggested by fate mapping experi-
ments using another inducible Plp-Cre-driver line, Plp-CreER (Doerflin-
ger, Macklin, & Popko, 2003). Using this line, it was reported that
melanocytes in hair follicles, but not in the interfollicular epidermis of
the tail, originate from Plp-Cre-positive glial cells at E11.5 in the mouse
(Deo, Huang, Fuchs, de Angelis, & Van Raamsdonk, 2013). The poten-
tial of peripheral glia to generate nonglial cell types was also demon-
strated by alternative approaches, involving fate mapping with other
lineage-specific Cre-driver lines or single cell RNA sequencing (Espi-
nosa-Medina et al., 2014; Furlan et al., 2017; Uesaka, Nagashimada, &
Enomoto, 2015). The latter allowed generation of “pseudo-time” line-
age trajectories and revealed an intermediate cellular state in between
the states defining Schwann cell precursors and differentiated nonglial
cells, respectively (Furlan et al., 2017). Finally, the Plp-CreERT2 line
(Leone et al., 2003) was instrumental to demonstrate by fate mapping
that adult peripheral glia become activated upon skin wounding, detach
from axons, and colonize the wound bed to support wound healing in a
paracrine manner, without notable differentiation into other, nonglial
cell types (Parfejevs et al., 2018).
However, inducible Cre activity in the Plp-CreERT2 line turned out
not to be specific for the glial lineage (Hari et al., 2012; Leone et al.,
2003). Indeed, in PLP-CreERT2/R26R embryos, TM treatment at early
stages of neural crest development (E9.5) resulted in prominent label-
ing of peripheral neurons, glia, and melanocytes, i.e., a fate map highly
reminiscent of multipotent neural crest cells (Hari et al., 2012). The
expression pattern of b-galactosidase became gradually restricted upon
TM injection at later stages. However, at all stages examined, the mela-
nocytic lineage was marked with considerable efficiency upon PLP-
CreERT2-mediated recombination. Likewise, induction of PLP-CreERT2-
driven recombination in adult mice marked a substantial fraction of
skin melanocytes, independently of the Cre-reporter allele used (Parfe-
jevs et al., 2018). Some of this expression might be due to CreERT2
leakiness during early neural crest development, given that in adult skin
of both PLP-CreERT2/R26R-tdTomato and Sox10-iCreERT2/R26R-tdTo-
mato mice, about 25% of all hair follicles contain recombined melano-
cytes even in the absence of any TM treatment (Figure 2) (Parfejevs
and Sommer, unpublished). However, TM injection in the adult signifi-
cantly induced Cre-reporter expression in both peripheral glia and
melanocytes in the skin (Parfejevs et al., 2018), demonstrating persis-
tent activity of PLP-CreERT2 and Sox10-iCreERT2 in these adult tissues.
Thus, as with Sox10-CreERT2-expressing mice, different neural crest
derivatives can be traced by means of the PLP-CreERT2-line, albeit with
an apparently lower recombination efficiency. Recently, Kaucka and
colleagues made use of this feature to carry out clonal analysis of cra-
nial neural crest cells in PLP-CreERT2/R26R-Confetti embryos to confirm
data obtained with a Sox10-iCreERT2 line (Kaucka et al., 2016).
In conclusion, distinct genetic mouse lines are available for fate
mapping premigratory and migratory neural crest cells. Together with
Cre-driver lines specific for fate-restricted precursor cells that we have
not covered in the present review, there is an increasing tool set avail-
able to the community to study the neural crest lineage tree and the
molecular mechanisms shaping it. The finding that several Cre and
CreERT2 driver lines expected to exhibit lineage-specific expression
appear to mark multipotent neural crest cells (although with quite
divergent recombination efficiencies) could simply reflect unfaithful
transgene expression. Alternatively, however, migratory neural crest
cells as well as, for instance, cells in peripheral nerves might comprise
distinct subpopulations expressing supposedly lineage-specific markers
together with multipotency markers. Conceivably, such cell populations
may be more or less ready to respond to the activity of cues controlling
fate decisions during development or upon injury. To address such
issues, the genetic approaches for prospective lineage tracing of neural
crest cells described herein will have to be complemented with other
methods, notably including retrospective lineage tracing by single cell
transcriptome analysis.
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